Werewolf Therapeutics, Inc. (HOWL)
$0.99+1.02%Close
SELLRECOVERY · day 3
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $48M
- Beta
- 0.29
- P/E (TTM)
- -1.35
- Short % float
- 5.91%
- Days to cover
- 3.7
- SI change
- +47.2%
- 1W
- +7.61%
- 1M
- +3.13%
- vs SPY 1W
- +7.75%
- vs SPY 1M
- +0.62%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
EARNINGS HISTORY
LOADING…Loading earnings…
Company news
FAQ
- What is LOPJLB’s current signal on HOWL?
- LOPJLB’s latest quantitative signal on Werewolf Therapeutics, Inc. (HOWL) is SELL in a RECOVERY regime. Signals are updated daily.
- What market regime is HOWL in?
- Werewolf Therapeutics, Inc. (HOWL) is currently classified in the RECOVERY HMM market regime on LOPJLB.
- What does Werewolf Therapeutics, Inc. (HOWL) do?
- Werewolf Therapeutics, Inc. is a biopharmaceutical firm dedicated to developing novel therapies that activate the body's immune system to combat cancer. Leveraging its exclusive PREDATOR platform, the company crafts conditionally activated molecules designed to stimulate both adaptive and innate immunity. This strategic approach aims to circumvent the shortcomings often associated with traditio…